Non-viral engineering of CAR-NK cells for cancer immunotherapy (2020)
- Authors:
- USP affiliated authors: ANTONIETTO, KAMILLA SWIECH - FCFRP ; FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; COVAS, DIMAS TADEU - FMRP ; CASTRO, VIRGÍNIA PICANÇO E - FMRP ; GOMES, KAUAN RIBEIRO DE SENA - FMRP ; SILVESTRE, RENATA NACASAKI - FMRP ; AZEVEDO, JÚLIA TEIXEIRA COTTAS DE - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.1016/j.htct.2020.10.706
- Subjects: LINFÓCITOS; CÉLULAS; IMUNOTERAPIA; NEOPLASIAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Hematology, Transfusion and Cell Therapy
- ISSN: 2531-1379
- Volume/Número/Paginação/Ano: v. 42, supl. 2, res. 704, p. S420, 2020
- Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020)
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
GOMES, Kauan Ribeiro de Sena et al. Non-viral engineering of CAR-NK cells for cancer immunotherapy. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.706. Acesso em: 27 dez. 2025. , 2020 -
APA
Gomes, K. R. de S., Silvestre, R. N., Azevedo, J. T. C. de, Swiech, K., Farias, K. C. R. M. de, Covas, D. T., & Picanço-Castro, V. (2020). Non-viral engineering of CAR-NK cells for cancer immunotherapy. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.706 -
NLM
Gomes KR de S, Silvestre RN, Azevedo JTC de, Swiech K, Farias KCRM de, Covas DT, Picanço-Castro V. Non-viral engineering of CAR-NK cells for cancer immunotherapy [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S420.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.htct.2020.10.706 -
Vancouver
Gomes KR de S, Silvestre RN, Azevedo JTC de, Swiech K, Farias KCRM de, Covas DT, Picanço-Castro V. Non-viral engineering of CAR-NK cells for cancer immunotherapy [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S420.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.htct.2020.10.706 - Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment
- Optimizing intracellular signaling domains for CAR-NK cells
- Chimeric antigen receptor T Cells: development and production
- Chimeric antigen receptor T Cell: development and production
- Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio]
- Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies
- Emerging CAR T cell therapies: clinical landscape and patent technological routes
- CAR-T cells for cancer treatment: current design and next frontiers
- Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives
- Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy
Informações sobre o DOI: 10.1016/j.htct.2020.10.706 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003031968.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
